Role of the measurement of serum procollagen type III N-terminal peptide in the evaluation of liver diseases
Authors:
- 30 June 1994
- journal article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 227 (1-2) , 37-43
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Biochemical markers of hepatic fibrosisClinical Biochemistry, 1991
- Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitisJournal of Hepatology, 1991
- Procollagen III peptide and fibronectin in alcohol-related chronic liver disease: Correlations with morphological features and biochemical testsClinica Chimica Acta, 1989
- Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis?Digestive Diseases and Sciences, 1987
- Serum Procollagen Type III N‐Terminal Peptides and Laminin P1 Peptide in Alcoholic Liver DiseaseAlcohol, Clinical and Experimental Research, 1987
- Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitisGastroenterology, 1986
- A Radioimmunoassay Procedure for Type Iii Procollagen: Its Use in the Detection of Hepatic FibrosisHepatology, 1985
- The N-Terminal Propeptide of Collagen Type III in Serum Reflects Activity and Degree of Fibrosis in Patients with Chronic Liver Disease†Hepatology, 1984
- The Blue Glass and the Predictive Value of Serum Amino-Terminal Propeptide of Type III Procollagen as a Marker of Liver FibrosisHepatology, 1984
- Radioimmunoassay for type III procollagen peptide and its application to human liver diseaseEuropean Journal of Clinical Investigation, 1979